VERTEX PHARMACEUTICALS

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	2
2025	—	9	2
2024	—	5	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	8	2
2011	—	9	2
2010	—	4	1
2009	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TIBER CREEK GROUP	—	65
CORNERSTONE GOVERNMENT AFFAIRS, INC.	—	15
SALT POINT STRATEGIES	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	83
SENATE	83
Health & Human Services, Dept of (HHS)	15
Executive Office of the President (EOP)	14
White House Office	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	65
Budget/Appropriations	Budget/Appropriations	20
Pharmacy	Pharmacy	10
Defense	Defense	7
Medicare/Medicaid	Medicare/Medicaid	5
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	2
Science/Technology	Science/Technology	1
Copyright/Patent/Trademark	Copyright/Patent/Trademark	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1227119th Congress

Alternatives to PAIN Act

2026 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1227

H.R. 1518119th Congress

New Era of Preventing End-Stage Kidney Disease Act

2026 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1518

S. 475119th Congress

Alternatives to PAIN Act

2026 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 475

H.R. 1227119th Congress

Alternatives to PAIN Act

2026 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1227

Show 21 more cited filings

H.R. 1518119th Congress

New Era of Preventing End-Stage Kidney Disease Act

2026 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1518

S. 475119th Congress

Alternatives to PAIN Act

2026 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 475

H.R. 1227119th Congress

Alternatives to PAIN Act

2026 · first_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1227

H.R. 1518119th Congress

New Era of Preventing End-Stage Kidney Disease Act

2026 · first_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1518

S. 475119th Congress

Alternatives to PAIN Act

2026 · first_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 475

H.R. 1227119th Congress

Alternatives to PAIN Act

2025 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1227

S. 475119th Congress

Alternatives to PAIN Act

2025 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 475

H.R. 1227119th Congress

Alternatives to PAIN Act

2025 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1227

H.R. 3838119th Congress

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

2025 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 3838

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2025 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Client expense: — · Firm income: $60,000

Matched citations: S. 2296

S. 475119th Congress

Alternatives to PAIN Act

2025 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 475

H.R. 1227119th Congress

Alternatives to PAIN Act

2025 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 1227

H.R. 3838119th Congress

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

2025 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to opioid alternatives; Issues related to H.R. 3838 - SPEED Act; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 3838

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2025 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to opioid alternatives; Issues related to H.R. 3838 - SPEED Act; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Client expense: — · Firm income: $80,000

Matched citations: S. 2296

S. 475119th Congress

Alternatives to PAIN Act

2025 · second_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 475

H.R. 7142118th Congress

Alternatives to PAIN Act

2025 · first_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 7142/S. 3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 7142

S. 3832118th Congress

Alternatives to PAIN Act

2025 · first_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R. 7142/S. 3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 3832

H.R. 7142118th Congress

Alternatives to PAIN Act

2024 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.7142

S. 3832118th Congress

Alternatives to PAIN Act

2024 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: S.3832

H.R. 7142118th Congress

Alternatives to PAIN Act

2024 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.7142

S. 3832118th Congress

Alternatives to PAIN Act

2024 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Client expense: — · Firm income: $80,000

Matched citations: S.3832

Source: Senate LDA

VERTEX PHARMACEUTICALS — Lobbying Disclosure | Poliscope